Back
Controladora Vuela Compania de Aviacion SAB de CV 10K Form
Sell
28
VLRS
Controladora Vuela Compania de Aviacion SAB de CV
Last Price:
$4.67
Seasonality Move:
0.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VLRS News And Ratings
See the #1 stock for the next 7 days that we like better than VLRS
VLRS Financial Statistics
Sales & Book Value
Annual Sales: | $3.1B |
---|---|
Cash Flow: | $157M |
Price / Cash Flow: | 0.54 |
Annual Sales: | $2.74 |
Price / Book: | 1.69 |
Profitability
EPS (TTM): | -3.70000 |
---|---|
Net Income (TTM): | $41.4M |
Gross Margin: | $515.5M |
Return on Equity: | 13.24% |
Return on Assets: | 0.75% |
Controladora Vuela Compania de Aviacion SAB de CV Earnings Forecast
Key Controladora Vuela Compania de Aviacion SAB de CV Financial Ratios
-
The Gross Profit Margin over the past 15 years for VLRS is 16.41%.
-
The Selling, General & Administrative Expenses for VLRS have been equal to 8.99% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 230.18% of Operating Income.
-
The Net Earning history of VLRS is 4.02% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Controladora Vuela Compania de Aviacion SAB de CV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Passenger Airlines |
Sector: | Industrials |
Current Symbol: | VLRS |
CUSIP: | 21240E |
Website: | volaris.com |
Debt
Debt-to-Equity Ratio: | 2.43 |
---|---|
Current Ratio: | 0.75 |
Quick Ratio: | 0.59 |
Price-to-Earnings
Trailing P/E Ratio: | 4.29 |
---|---|
Forward P/E Ratio: | 93.48 |
VLRS Technical Analysis vs Fundamental Analysis
Sell
28
Controladora Vuela Compania de Aviacion SAB de CV (VLRS)
is a Sell
Is Controladora Vuela Compania de Aviacion SAB de CV a Buy or a Sell?
-
Controladora Vuela Compania de Aviacion SAB de CV stock is rated a SellThe current Controladora Vuela Compania de Aviacion SAB de CV [VLRS] share price is $4.63. The Score for VLRS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.